Furthermore, Escin significantly reduced the serum levels of TSH, TgAb, Tg, and calcitonin related to thyroid cancer progression and recurrence and prolonged the PFS and OS for patients with advanced thyroid cancer. Here, TG is linked to thyroid gland carcinoma.